Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CRHBP | P24387 | 2/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.36 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3541107 | 0.86 | PPARG (0.38) | SRCPOLBADRA1ACYP2C19 | |
| SCHEMBL2519498 | 0.82 | CNR2 (0.41) | ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3539841 | 0.81 | KMT2A (0.40) | LMNAGAAALDH1A1POLBMEN1 | |
| SCHEMBL9465771 | 0.77 | LMNA (0.37) | LMNAALDH1A1TSHR | |
| SCHEMBL4016238 | 0.76 | PTGS2 (0.46) | LMNAHSD17B10AKR1C3AKR1C2ALDH1A1 | |
| SCHEMBL9467544 | 0.75 | SRC (0.54) | LMNAALDH1A1SRCPTGS1TSHR | |
| SCHEMBL692149 | 0.74 | SRC (0.34) | ALDH1A1SRC | |
| SCHEMBL3589887 | 0.73 | LMNA (0.48) | LMNATSHR | |
| SCHEMBL533187 | 0.72 | LMNA (0.32) | LMNATSHR | |
| SCHEMBL1715 | 0.72 | LMNA (0.59) | LMNAHSD17B10GAAALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2010-12-16 | — | — | US | claimed |
| US-7795283-B2 | Oxadiazole derivative as DGAT inhibitors | ASTRAZENECA AB (SE) | 2010-09-14 | — | — | US | claimed |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | claimed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | claimed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| US-20060049052-A1 | Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2006-03-09 | — | — | US | claimed |
| US-8852727-B2 | Ink composition, image forming method, and printed matter | FUJIFILM CORPORATION (JP) | 2014-10-07 | — | — | US | disclosed |
| EP-2664658-A1 | INK COMPOSITION, IMAGE FORMING METHOD, AND PRINT | FUJIFILM Corporation (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-20130295344-A1 | INK COMPOSITION, IMAGE FORMING METHOD, AND PRINTED MATTER | FUJIFILM CORPORATION (JP) | 2013-11-07 | — | — | US | disclosed |
| EP-2492322-A1 | Ink composition, image forming method, and printed material | Fujifilm Corporation (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120213978-A1 | INK COMPOSITION, IMAGE FORMING METHOD, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2010-12-16 | — | — | US | disclosed |
| US-7795283-B2 | Oxadiazole derivative as DGAT inhibitors | ASTRAZENECA AB (SE) | 2010-09-14 | — | — | US | disclosed |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | disclosed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | disclosed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| EP-0780730-B1 | Positive-type light-sensitive lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2002-08-21 | — | — | EP | disclosed |
| EP-0780730-A2 | Positive-type light-sensitive lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1997-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | DGAT1, DGAT2, GPR119 | LMNA 3296/4885HSD17B10 151/4885GAA 171/4885 |
| US-20060049052-A1 | Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form | ALPP, CA2, CA1 | LMNA 1941/4885HSD17B10 2310/4885GAA 80/4885 |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | DGAT1, DGAT2, GPR119 | LMNA 3477/4885HSD17B10 166/4885GAA 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.